Alkem Laboratories Ltd. (Alkem) announced the launch of Ibuprofen and Famotidine Tablets (800 mg/26.6 mg) in the United States, following approval from the United States Food and Drug Administration (US FDA). Ibuprofen and Famotidine Tablets is an AB-rated generic therapeutic equivalent version of Horizon Medicines LLC's Duexis Tablets, 800 mg/26.6 mg.

 This is the first generic approval of Duexis Tablets, 800 mg/26.6 mg by the US FDA. The launch is a subject of ongoing litigation.